Diaxonhit SA Share Price Euronext Paris
Equities
ALEHT
FR0013240934
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
11/04 | Eurobio Scientific: 2023 results down, share price falls | CF |
30/01 | Eurobio Scientific Société anonyme acquired Alpha Biotech Ltd. | CI |
Sales 2023 | 130M 140M 11.69B | Sales 2024 * | 138M 149M 12.41B | Capitalization | 148M 160M 13.33B |
---|---|---|---|---|---|
Net income 2023 | 4M 4.31M 360M | Net income 2024 * | 9M 9.7M 809M | EV / Sales 2023 | 1.29 x |
Net Debt 2023 * | 8.8M 9.48M 791M | Net cash position 2024 * | 9.9M 10.67M 890M | EV / Sales 2024 * | 1 x |
P/E ratio 2023 |
38.3
x | P/E ratio 2024 * |
15.3
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 61.3% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 19/17/19 |
Director of Finance/CFO | 43 | 01/22/01 | |
Cathie Marsais
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 19/17/19 |
Director/Board Member | 68 | 04/09/04 | |
Director/Board Member | 67 | 15/17/15 |
1st Jan change | Capi. | |
---|---|---|
+22.81% | 47.9B | |
+46.56% | 41.42B | |
-1.88% | 40.7B | |
-6.20% | 28.92B | |
+11.33% | 25.55B | |
-21.00% | 19.27B | |
-1.43% | 12.15B | |
+30.73% | 12.14B | |
-0.48% | 11.99B |
- Stock Market
- Equities
- ALERS Stock
- ALEHT Stock